The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Feasibility of risk stratified allocation to single versus tandem autologous SCT in multiple myeloma.
Matthew Risendal
Disclosure not yet available
Allison Hazlett
Disclosure not yet available
Roy T. Sabo
Disclosure not yet available
Priscilla Mpasi
Disclosure not yet available
Joan Bolling
Disclosure not yet available
William B. Clark
Disclosure not yet available
John McCarty
Disclosure not yet available
Harold M. Chung
Disclosure not yet available
Catherine H. Roberts
Disclosure not yet available
Amir A. Toor
Disclosure not yet available